Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

SZSE:300534.SZ

9.22 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Omzet 255.382291.889254.914267.744220.834295.149296.323189.75173.11495.12355.259121.12659.00458.5349.15486.9672.44847.66547.82677.23751.30852.36558.09349.81342.3953.09257.87176.38562.83472.52157.84780.83265.47277.21246.16589.6358.772
Kosten van de omzet 92.65673.52667.036118.48873.44291.849102.451116.07345.26154.54633.64377.45440.48140.87936.60752.23847.80637.32934.42648.77930.97734.19934.58324.93122.75833.32835.74850.2441.86548.90840.45151.95141.82948.529.63556.42134.518
Brutowinst 162.726218.363187.878149.256147.392203.3193.87273.67827.85340.57721.61643.67218.52217.65112.54734.72224.64310.33613.39928.45820.3318.16623.5124.88219.63219.76422.12326.14520.96923.61317.39728.88123.64328.71116.5333.2124.254
Brutowinstmarge 0.6370.7480.7370.5570.6670.6890.6540.3880.3810.4270.3910.3610.3140.3020.2550.3990.340.2170.280.3680.3960.3470.4050.50.4630.3720.3820.3420.3340.3260.3010.3570.3610.3720.3580.3710.413
Onderzoek- en ontwikkelingskosten 4.9496.0143.9849.5226.3148.6195.7184.092.1411.6431.52.4941.6491.3871.1681.8741.1491.3981.5533.6911.1971.2941.233.3431.3561.0061.0272.0941.8542.18806.35603.908010.190
Algemene en administratieve kosten 25.641-3.63110.636-16.29225.322-5.15312.73-8.16114.597-2.8995.291-10.4913.127-3.2585.347-11.6244.204-2.8474.96-11.975.572-3.1514.793-8.9374.079-3.4735.126-12.4126.269-3.0664.98-10.0663.935-3.0043.732-9.8422.65
Verkoop- en marketingkosten 133.466184.113135.089103.926110.453155.029138.61933.49215.34728.84314.02224.79121.13515.3855.87715.96417.77913.9564.98911.62314.70810.0969.18415.32614.7548.3618.82215.47114.9111.0895.09712.0256.5436.071.1164.71.919
Verkoop-, algemene en administratieve kosten 159.107193.643145.72587.634135.775149.876151.34925.33129.94425.94419.31314.30134.26212.12711.2244.3421.98311.1099.949-0.34720.286.94513.9776.38918.8334.88713.9483.05921.1798.02410.0761.95910.4783.0664.847-5.1414.569
Overige kosten -15.617-2.2890.0512.142-0.03-0.27-0.0235.3250.328-0.18600.472-0.1144.323-0.0461.7110.079-0.21-0.0070.827-0.3270.001-0-0.044-0.0010.036-00.0210.0121.6832.3772.4051.3180.6010.2980.6370.258
Bedrijfskosten 148.44199.657151.886128.948127.566176.224159.76551.54824.30636.8121.16637.3526.69921.18712.30222.91922.84320.76311.71714.26621.76615.23615.88523.28719.16514.36914.64423.46721.30317.50911.25219.61211.1111.6615.4612.5985.311
Bedrijfsresultaat 15.16518.70636.4520.58920.43518.83835.33715.7914.1695.8690.9031.918-7.684-3.9490.33111.1481.707-12.1281.51810.954-1.4652.1447.8990.9430.6314.3557.5953.156-1.0365.2536.6488.38413.87215.99411.86218.63418.716
Bedrijfsresultaat ratio 0.0590.0640.1430.0770.0930.0640.1190.0830.0570.0620.0160.016-0.13-0.0670.0070.1280.024-0.2540.0320.142-0.0290.0410.1360.0190.0150.0820.1310.041-0.0160.0720.1150.1040.2120.2070.2570.2080.318
Totaal overige inkomsten en kosten netto -0.0280.3780.509-10.124-0.03-0.27-0.0235.3250.328-0.18600.472-0.1144.323-0.0461.7110.079-0.21-0.0070.827-0.3270.001-0-0.044-0.0010.036-00.0210.0121.6832.3772.4051.3180.6010.2980.6370.258
Inkomen voor belasting 15.13719.08536.50122.73120.40518.56935.31421.1164.4985.6830.9032.39-7.7980.3740.28512.8591.786-12.3381.51111.782-1.7922.1457.8990.8990.634.3927.5943.178-1.0246.9379.02510.78815.1916.59512.1619.27118.974
Inkomen voor belasting ratio 0.0590.0650.1430.0850.0920.0630.1190.1110.0620.060.0160.02-0.1320.0060.0060.1480.025-0.2590.0320.153-0.0350.0410.1360.0180.0150.0830.1310.042-0.0160.0960.1560.1330.2320.2150.2630.2150.323
Belastingkosten 4.40113.0765.6981.8132.9542.3816.02-0.5680.6021.710.161.5650.3-0.3610.045-0.1861.877-1.6820.5273.092-0.020.3821.216-0.7410.6720.131.176-1.041-00.6711.3731.1022.2532.2861.842.0352.858
Nettowinst 3.314-0.68822.14114.8214.63412.18820.00520.3783.4881.3510.611-0.919-8.480.1020.19114.591-2.219-10.750.2097.334-2.5991.366.6831.64-0.0424.2626.4184.219-1.0246.2667.6529.68712.93714.30910.3217.23616.117
Nettowinstmarge 0.013-0.0020.0870.0550.0660.0410.0680.1070.0480.0140.011-0.008-0.1440.0020.0040.168-0.031-0.2260.0040.095-0.0510.0260.1150.033-0.0010.080.1110.055-0.0160.0860.1320.120.1980.1850.2240.1920.274
WPA (Winst Per Aandeel) 0.011-0.0020.0730.0490.0480.040.0660.0670.0120.0040.002-0.003-0.02800.0010.047-0.007-0.0350.0010.024-0.0090.0050.0220.005-00.0140.0210.014-0.0030.0210.0250.0320.0570.0630.0450.0760.071
Verwaterde WPA 0.011-0.0020.0730.0490.0480.040.0660.0670.0120.0040.002-0.003-0.02800.0010.047-0.007-0.0350.0010.024-0.0090.0050.0220.005-00.0140.0210.014-0.0030.0210.0250.0320.0570.0630.0450.0760.071
EBITDA 15.60426.76237.4124.09121.49119.65236.00631.3641.1776.1370.4497.274-7.8860.2570.93713.8522.388-11.7031.8315.184-1.7212.937.6251.3240.4675.3947.4791.9120.5359.8176.14516.46612.30918.36911.0722.87119.328
EBITDA ratio 0.0610.0920.1470.090.0970.0670.1220.1650.0160.0650.0080.06-0.1340.0040.0190.1590.033-0.2460.0380.197-0.0340.0560.1310.0270.0110.1020.1290.0250.0090.1350.1060.2040.1880.2380.240.2550.329